Depression and Anxiety Trial, Recruiting (NCT07262801)

Depression and Anxiety Trial, Recruiting NCT07262801 Sponsor: St. Joseph's Healthcare Hamilton Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT07262801 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Mothers or birthing parents who are 18 years of age or older and whose baby is between 0 and 12 months old
People whose primary diagnosis is an anxiety disorder, as confirmed by a specific diagnostic tool called the DART, with or without depression as well
People who are not currently receiving any other psychological therapy or counselling
People who are either not taking any psychiatric medications, or whose psychiatric medication type and dose has remained unchanged for at least 8 weeks before the study and will stay the same throughout the study
People who are fluent in English and have at least a Grade 8 reading level

Who may not be able to join:

People experiencing severe depression or thoughts of suicide that require immediate care
People who have a psychotic disorder, or a current alcohol or substance use disorder
People who experience severe claustrophobia (intense fear of enclosed spaces)
People who have metal objects in their body, such as metal implants or a pacemaker
People who are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sheryl M Green, Ph.D., C.Psych, St. Joseph's Healthcare Hamilton

Phone: 905-522-1155

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07262801

Sponsor: St. Joseph's Healthcare Hamilton

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

Trial contact: 905-522-1155

More information: https://clinicaltrials.gov/study/NCT07262801

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Mothers or birthing parents who are 18 years of age or older and whose baby is between 0 and 12 months old
People whose primary diagnosis is an anxiety disorder, as confirmed by a specific diagnostic tool called the DART, with or without depression as well
People who are not currently receiving any other psychological therapy or counselling
People who are either not taking any psychiatric medications, or whose psychiatric medication type and dose has remained unchanged for at least 8 weeks before the study and will stay the same throughout the study
People who are fluent in English and have at least a Grade 8 reading level

Who may not be able to join:

People experiencing severe depression or thoughts of suicide that require immediate care
People who have a psychotic disorder, or a current alcohol or substance use disorder
People who experience severe claustrophobia (intense fear of enclosed spaces)
People who have metal objects in their body, such as metal implants or a pacemaker
People who are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

St. Joseph's Healthcare Hamilton

Registry

ClinicalTrials.gov

Start date

1 December 2025

Est. completion

1 September 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

State-Trait Inventory for Cognitive and Somatic Anxiety (STICSA)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov